IOVANCE BIOTHERAPEUTICS, INC. ·

IOVA 8-K 2026-08-06

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) 8-K dated 2026-08-06 — accession 0001104659-26-091619. This URL is the filing, not the IOVA hub.

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a biotechnology company listed on US.

IOVANCE BIOTHERAPEUTICS, INC. filed a 8-K on 2026-08-06. Accession 0001104659-26-091619.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. IOVA currently screens at market cap $1.89B.

Not investment advice. The IOVA SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR